Inari Medical is proud to offer health economics, reimbursement resources and support, to assist you with the key elements of medical documentation for the coding and billing of our Transcatheter Arterialization of Deep Veins (TADV) procedures. Our dedicated team of field-based Health Economic and Market Access (HEMA) Managers deliver unmatched support in the industry, serving as your partner in navigating through the complex and changing reimbursement landscape.
Contact Reimbursement@inarimedical.com to learn more
CMS APPROVES NTAP
CMS grants new technology add-on payment (NTAP) for the LimFlow System effective October 1, 2024.
Watch the video below to learn more:
Medicare Increases Hospital Outpatient and ASC
Payment for LimFlow TADV
Effective January 1, 2025, Medicare will reassign the LimFlow TADV procedure (CPT 0620T) from New
Technology APC 1578 to New Technology APC 1579, which has an average payment amount of $35,001
in the hospital outpatient department (HOPD) and an average payment of $31,714 in the ambulatory
surgical center (ASC).
This positive reassignment represents a 27% increase in hospital outpatient patient and a 29% increase
in ASC payment for LimFlow TADV from 2024. Additionally, the facility payment for LimFlow TADV is
not subject to multiple procedure discounting. Medicare finalized these positive updates in the 2025
Medicare Hospital Outpatient Prospective Payment System Rule released on Friday, November 5, 2024.
YoY Hospital Outpatient Department (HOPD) and Ambulatory Surgical Center (ASC) National Average Medicare Payment
As a reminder, effective October 1, 2024, hospital inpatient LimFlow TADV cases are eligible for an
incremental payment of up to $16,250 from Medicare in addition to the applicable MS-DRG payment
for the case. This incremental reimbursement is called a “New Technology Add-on Payment” or NTAP.
Sources:
Medicare FFS Outpatient Hospital Rates effective January 1, 2024 through December 31, 2024.; Source: CY 2024 OPPS Final Rule; hospital impact file, Addendum A
Medicare FFS Outpatient Hospital Rates effective January 1, 2025 through December 31, 2025.; Source: CY 2025 OPPS Final Rule; hospital impact file, Addendum A
LimFlow NTAP finalized in FY 2025 IPPS Final Rule (CMS-1808-F).
BILLING AND CODING LIMFLOW TADV PROCEDURES WITH DR. Z
Gain valuable insights and expert guidance on billing and coding for these advanced procedures directly from Dr. Z, nationally recognized coding expert. During this on-demand webinar, Dr. Z will share best practices, tips, and strategies on billing and coding for LimFlow TADV procedures, ensuring appropriate reimbursement and and adherence to billing guidelines.
Attendees earn 1 CEU toward the American Academy of Professional Coders (AAPC) and is CIRCC certified. Also eligible for AHIMA CE credit
REIMBURSEMENT RESOURCES & SUPPORT
Please complete the following form to access our available LimFlow reimbursement resources.
PLEASE NOTE:
Health economic and reimbursement information provided by LimFlow is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice. LimFlow encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered. LimFlow recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage and reimbursement matters. LimFlow does not promote the use of the LimFlow System outside of its FDA-approved indications.